We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BIOBASE

The BIOBASE Group focuses on the development, production and management of scientific equipment, in vitro diagnosis (... read more Featured Products: More products

Download Mobile App





BIOBASE Showcases Comprehensive Range of Laboratory Solutions

By LabMedica International staff writers
Posted on 06 Feb 2025

BIOBASE (Shandong, China) is presenting its most popular laboratory products at Medlab Middle East 2025, including clinical chemistry, electrolyte and immunoassay analyzers. More...

The BK-410 automatic chemistry analyzer featured at the event is engineered to streamline laboratory workflows, providing reliable and precise results with unparalleled speed. Its comprehensive feature set makes it an invaluable asset for high-volume testing environments, ensuring accurate diagnostics and efficient laboratory operations. Featured alongside is the BKI1100 automatic chemiluminescence immunoassay system which uses magnetic particle separation technology for faster reaction speed and higher efficiency. BIOBASE is demonstrating the BK-EL10C ELISA microplate reader which uses enzyme-linked immunosorbent assay (ELISA) and other experimental methods to measure the absorbance and fluorescence intensity of reactants to quantitatively analyze specific components in samples.

BIOBASE is also showcasing the BKE-B electrolyte analyzer which adopts advanced ion-selective electrode measurement technology and is a fast, accurate, convenient, and practical clinical testing instrument. It can directly measure the concentration of K+, Na+, Cl-, Ca2+, and pH in serum, plasma, whole blood, cerebrospinal fluid, and diluted urine. In addition, BIOBASE is demonstrating the BKP2000 multi-channel dry fluorescence immunoassay analyzer with 12 independent incubation channels. The instrument comprises an optical detection module (fluorescence), scanning module, data processing module, liquid crystal display module, incubation module, information acquisition module (ID card reader), power supply, and printer. It also features automatic induction of reagent card insertion, automatic printing of test results, and automatic card loss along with a 10.1-inch LCD screen for a better visual experience.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.